Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 10
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II Chemotherapy with Caracemide in Patients with Unresectable or Recurrent non-Small Cell Carcinoma of the Lung
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 to physiologic 70
NCI
UMCC-8532
NCI-T86-0005C, T86-0005
2.
Phase II Chemotherapy with Caracemide in Patients with Advanced or Recurrent Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
UMCC-8534
NCI-T86-0007C, T86-0007
3.
Phase II Master Protocol of New Agents in Patients with Advanced Unresectable non-Small Cell Bronchogenic Carcinoma --- Caracemide
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
ICC-86L1
NCI-T86-0012D, T86-0012
Last Modified:
6/1/1990
4.
Phase II Study of Chemotherapy with Caracemide in Patients with Advanced Large Bowel Cancer (Summary Last Modified 06/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
any age
NCI
EST-3287
Last Modified:
4/26/2007
5.
Phase II Randomized Evaluation of Single-Agent Chemotherapy with Amonafide or Caracemide in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 10/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
any age
NCI
EST-3888
Last Modified:
6/1/1989
6.
Phase II Study of Caracemide in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 06/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
NYMC-T88-0188
NCI-T88-0188O, T88-0188
Last Modified:
10/1/1989
7.
Phase II Study of Intravenous Caracemide in Patients with Advanced Breast Cancer (Summary Last Modified 10/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
NYMC-T89-0030
NCI-T89-0030O, T89-0030
8.
Phase I Evaluation of Caracemide
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
over 15
NCI
MDA-DM-8330
NCI-T83-0862W, T83-0862
9.
Phase I Chemotherapy with Caracemide in Adult Patients with Carcinomas, Sarcomas, or Lymphomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
over 18
NCI
WSU-A-52683
NCI-T84-0243W, T84-0243
10.
Phase I Chemotherapy with Intermittent Bolus Injections of Caracemide for Refractory Adult Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
over 18
NCI
PCCC-84154
NCI-T84-0316W, T84-0316
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute